News

17-09-2018 LEO Pharma and MorphoSys Expand Strategic Alliance to Develop Peptide-derived Therapeutics
13-09-2018 New data show LEO Pharma’s Kyntheum® (brodalumab) provides greater probability of achieving complete skin clearance for people with moderate to severe psoriasis compared with ustekinumab
12-09-2018 LEO Pharma to showcase two dozen data presentations at 27th annual European Academy of Dermatology and Venerology Congress in Paris

Annual Report 2017

Global presence

See LEO Pharma global presence See LEO Pharma global presence

By listening to people with skin conditions, LEO Pharma develops complete care solutions that meet patient needs
 

 

Working at LEO Pharma

We understand that people power our success. Our global team – consisting of around 5,000 people in 61 countries worldwide – is LEO Pharma’s greatest asset. This is why we continually seek to attract passionate, dedicated and solution-orientated people – and ensure that our people develop their talent.

Partner with LEO Pharma

We use cookies on this website

The cookies help us gain a better understanding of how you use our website; display applications and functionalities, to optimise your website experience, to assign a unique identification number to you, and to help you remember your user ID and password when you return to the website. We also use cookies to generate statistical information.

By continuing to browse our website, you are agreeing to our use of cookies

If you want to know more about our cookie policy and how to avoid and delete cookies click here.